News
EU approves AstraZeneca’s Calquence in combo with venetoclax, with or without obinutuzumab to treat adult patients with previously untreated CLL: Cambridge, UK Saturday, June 7, ...
The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah ...
President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is ...
The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on limiting prescription drug prices goes against a federal program.
Pharmaceutical giant AstraZeneca is suing Utah’s attorney general and insurance commissioner over a law passed during the ...
AstraZeneca, a major pharmaceutical company, has sued Utah’s Attorney General Derek Brown over a recently passed state law ...
13h
Zacks Investment Research on MSNWhy Astrazeneca (AZN) is a Top Growth Stock for the Long-TermIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...
The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...
16h
HealthDay on MSNImmunotherapy Effective Against Stomach CancerKey Takeaways An immunotherapy drug can boost survival in people with stomach or esophageal cancerWhen combined with chemo, ...
For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...
A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results